Basal and flow-mediated nitric oxide production by atheromatous coronary arteries

D Tousoulis1, C Tentolouris, T Crake

  • 1Cardiology Unit, Hippokration Hospital, Athens University Medical School, Greece.

Insights

Coronary artery dilation during increased heart rate relies on nitric oxide (NO). Inhibiting NO synthesis blocks this dilation in both normal and diseased human coronary arteries, confirming NO

Area of Science:

  • Cardiovascular physiology
  • Vascular biology
  • Nitric oxide research

Background:

  • Epicardial coronary arteries dilate with increased heart rate.
  • The role of nitric oxide in this dilation for human coronary arteries (normal and diseased) is unclear.

Purpose of the Study:

  • To investigate the effect of inhibiting nitric oxide synthesis on human epicardial coronary arteries.
  • To assess the impact on coronary flow velocity during baseline and atrial pacing.

Main Methods:

  • Intracoronary infusion of NG-monomethyl-L-arginine (LNMMA), a nitric oxide synthesis inhibitor.
  • Quantitative angiography to measure epicardial coronary artery lumen diameter.
  • Doppler catheter to measure coronary blood flow velocity during atrial pacing.

Main Results:

  • Atrial pacing increased lumen diameter during saline infusion but not during LNMMA infusion.
  • Coronary blood flow velocity changes with pacing were reduced when nitric oxide synthesis was inhibited.
  • Nitric oxide production was present at stenosis sites but unaffected by pacing.

Conclusions:

  • Epicardial coronary artery dilation due to pacing is dependent on nitric oxide.
  • Nitric oxide contributes significantly to the vasomotor tone of coronary resistance vessels.
  • Nitric oxide is produced in stenotic lesions, independent of pacing stimuli.
Abstract

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...